SGX reduces licence agreement with MSCI from February 2021; continues to serve global investors with pan-Asian multi-asset solutions
SGX and MSCI will retain their partnership on MSCI Singapore Index products and will both work to extend it well beyond 2021; MSCI Singapore futures and options remain listed
Licence agreement for all other MSCI products will expire in February 2021
SGX continues to grow a one-stop, multi-asset platform to trade and manage Asian risk comprehensively across equities, fixed income, currencies and commodities
